Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation - PubMed (original) (raw)
Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation
Lene Melsaether Grøvdal et al. Exp Cell Res. 2004.
Abstract
Mutation of the binding site for Cbl (Tyr1045) in the EGF receptor (EGFR) results in impaired ubiquitination but does not affect EGFR internalization. However, the Y1045F mutation resulted in strongly decreased degradation of the EGFR, as well as efficient recycling of EGFR to the plasma membrane. Significantly, more wild-type EGFR than Y1045F EGFR was found localizing to multivesicular late endosomes. Ubiquitination of the EGFR was in HeLa cells inhibited both upon overexpressing the N-terminal part of Cbl and upon overexpressing a double mutant Grb2 incapable of interacting with Cbl and thereby being incapable of indirectly recruiting Cbl to the EGFR. Collectively, these data suggest that the ubiquitination resulting from direct binding of Cbl to pTyr1045 of the EGFR is critical for lysosomal sorting of the EGFR in contrast to ubiquitination resulting from Grb2-mediated binding of Cbl to the EGFR.
Similar articles
- Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS, Langdon WY. Oksvold MP, et al. Oncogene. 2003 Nov 20;22(52):8509-18. doi: 10.1038/sj.onc.1207117. Oncogene. 2003. PMID: 14627991 - Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.
Oksvold MP, Skarpen E, Wierød L, Paulsen RE, Huitfeldt HS. Oksvold MP, et al. Eur J Cell Biol. 2001 Apr;80(4):285-94. doi: 10.1078/0171-9335-00160. Eur J Cell Biol. 2001. PMID: 11370743 - Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM, van Rotterdam W, van Zoelen EJ, van Leeuwen JE. Meijer IM, et al. Cell Signal. 2013 Feb;25(2):470-8. doi: 10.1016/j.cellsig.2012.11.008. Epub 2012 Nov 12. Cell Signal. 2013. PMID: 23153581 - [Ubiquitination-mediated degradation of epidermal growth factor receptor].
Xiu X, Lü ZM. Xiu X, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):120-7. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005. PMID: 15782507 Review. Chinese. - Life and death decisions: ceramide generation and EGF receptor trafficking are modulated by oxidative stress.
Goldkorn T, Ravid T, Khan EM. Goldkorn T, et al. Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):119-28. doi: 10.1089/ars.2005.7.119. Antioxid Redox Signal. 2005. PMID: 15650401 Review.
Cited by
- Targeting the EGFR signaling pathway in cancer therapy.
Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Seshacharyulu P, et al. Expert Opin Ther Targets. 2012 Jan;16(1):15-31. doi: 10.1517/14728222.2011.648617. Epub 2012 Jan 12. Expert Opin Ther Targets. 2012. PMID: 22239438 Free PMC article. Review. - Cbl and Cbl-b independently regulate EGFR through distinct receptor interaction modes.
Pinilla-Macua I, Sorkin A. Pinilla-Macua I, et al. Mol Biol Cell. 2023 Dec 1;34(13):ar134. doi: 10.1091/mbc.E23-02-0058. Epub 2023 Oct 30. Mol Biol Cell. 2023. PMID: 37903221 Free PMC article. - Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.
Fiori JL, Zhu TN, O'Connell MP, Hoek KS, Indig FE, Frank BP, Morris C, Kole S, Hasskamp J, Elias G, Weeraratna AT, Bernier M. Fiori JL, et al. Endocrinology. 2009 Jun;150(6):2551-60. doi: 10.1210/en.2008-1344. Epub 2009 Feb 12. Endocrinology. 2009. PMID: 19213840 Free PMC article. - Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab.
Hughes JB, Rødland MS, Hasmann M, Madshus IH, Stang E. Hughes JB, et al. Pharmaceuticals (Basel). 2012 Jun 28;5(7):674-89. doi: 10.3390/ph5070674. Pharmaceuticals (Basel). 2012. PMID: 24281706 Free PMC article. - NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer.
Yang G, Huang L, Jia H, Aikemu B, Zhang S, Shao Y, Hong H, Yesseyeva G, Wang C, Li S, Sun J, Zheng M, Ma J. Yang G, et al. Oncogene. 2021 Oct;40(41):5993-6006. doi: 10.1038/s41388-021-01962-8. Epub 2021 Aug 12. Oncogene. 2021. PMID: 34385595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous